Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
November 08, 2017 18:20 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)
October 23, 2017 17:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company), an Australian biopharmaceutical company focused on the development of diagnostic and...